Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 177,888	$ 167,299
Restricted cash	30	331
Marketable securities	99,323	95,111
Trade accounts receivable, net	44,643	55,928
Inventories	50,070	60,877
Prepaid expenses and other current assets	12,130	12,514
Total current assets	384,084	392,060
Deferred income tax assets, noncurrent	29,676	30,487
Property and equipment, net	18,114	18,405
Operating lease right-of-use assets	9,328	10,853
Goodwill	16,183	16,183
Intangible assets, net	21,420	23,084
Other noncurrent assets	4,920	3,385
Total assets	483,725	494,457
Current liabilities:
Trade accounts payable	3,191	3,032
Legal settlement liability, current	2,503	2,561
Accrued expenses	15,489	20,035
Other current liabilities	7,228	7,903
Deferred revenue, current	23,968	22,695
Total current liabilities	52,379	56,226
Legal settlement liability, noncurrent	16,912	16,477
Deferred revenue, noncurrent	14,064	15,132
Operating lease liability, noncurrent	8,113	9,479
Long term debt	1,330	1,648
Other noncurrent liabilities	1,804	2,431
Total liabilities	94,602	101,393
Commitments and contingencies (Note 18)
Stockholders’ equity:
Common stock, $0.001 par value; 1,000,000,000 authorized shares as of June 30, 2024 and December 31, 2023, respectively; 131,505,201 and 130,714,906 issued and outstanding shares as of June 30, 2024 and December 31, 2023, respectively.	132	131
Additional paid-in capital	434,967	423,386
Accumulated deficit	(45,781)	(29,178)
Accumulated other comprehensive loss	(195)	(1,275)
Total stockholders’ equity	389,123	393,064
Total liabilities and stockholders’ equity	$ 483,725	$ 494,457